NasdaqGS - Nasdaq Real Time Price USD
Phathom Pharmaceuticals, Inc. (PHAT)
3.9600
+0.0600
+(1.54%)
At close: April 22 at 4:00:01 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 212,200 | 7 |
| Sales | 39,665 | 6 |
| Net Shares Purchased (Sold) | 172,535 | 13 |
| Total Insider Shares Held | 2.67M | -- |
| % Net Shares Purchased (Sold) | 6.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SCHROEDER THEODORE R Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 16, 2025 |
| HENDERSON MOLLY Chairman of the Board | Sale at price 4.55 per share. | Direct | 16,740 | Apr 7, 2025 |
| PARIKH ASIT Director | Purchase at price 4.42 per share. | Direct | 44,200 | Mar 13, 2025 |
| HENDERSON MOLLY Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2025 |
| NABULSI AZMI M.D. Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2025 |
| HENDERSON MOLLY Chairman of the Board | Sale at price 6.59 per share. | Direct | 43,371 | Jan 21, 2025 |
| CURRAN TERRIE President | Sale at price 6.59 per share. | Direct | 125,884 | Jan 21, 2025 |
| NABULSI AZMI M.D. Chief Operating Officer | Sale at price 6.59 per share. | Direct | 51,957 | Jan 21, 2025 |
| HENDERSON MOLLY Chairman of the Board | Sale at price 8.00 per share. | Direct | 10,328 | Dec 19, 2024 |
| NABULSI AZMI M.D. Chief Operating Officer | Sale at price 8.00 per share. | Direct | 8,944 | Dec 19, 2024 |
| KARBE FRANK L Director | Purchase at price 7.93 per share. | Direct | 99,084 | Dec 13, 2024 |
| PARIKH ASIT Director | Purchase at price 8.12 per share. | Direct | 81,248 | Dec 13, 2024 |
| PARIKH ASIT Director | Conversion of Exercise of derivative security at price 11.72 per share. | Direct | 87,900 | Sep 10, 2024 |
| HENDERSON MOLLY Chairman of the Board | Sale at price 11.72 per share. | Direct | 50,689 | Jul 15, 2024 |
| CURRAN TERRIE Chief Executive Officer | Sale at price 11.72 per share. | Direct | 396,699 | Jul 15, 2024 |
| NABULSI AZMI M.D. Chief Operating Officer | Sale at price 11.72 per share. | Direct | 127,760 | Jul 15, 2024 |
| HENDERSON MOLLY Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| NABULSI AZMI M.D. Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| KARBE FRANK L Director | Stock Award(Grant) at price 10.16 per share. | Direct | 254,112 | May 29, 2024 |
| FIELDS-KUNZ HEIDI Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 23, 2024 |
| KARBE FRANK L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 23, 2024 |
| TOPPER JAMES N Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 23, 2024 |
| SOCKS DAVID A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 23, 2024 |
| STENHOUSE MARK Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 23, 2024 |
| COLA MICHAEL F Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 23, 2024 |
| PARIKH ASIT Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 23, 2024 |
| HENDERSON MOLLY Chief Financial Officer | Sale at price 11.10 per share. | Direct | 38,128 | Apr 8, 2024 |
| CURRAN TERRIE Chief Executive Officer | Sale at price 9.11 per share. | Direct | 153,513 | Mar 22, 2024 |
| TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security | Sale at price 6.70 per share. | Direct | 24,833,329 | Jan 24, 2024 |
| HENDERSON MOLLY Chairman of the Board | Sale at price 7.75 per share. | Direct | 48,900 | Jan 19, 2024 |
| HENDERSON MOLLY Chief Financial Officer | Sale at price 7.24 per share. | Direct | 15,403 | Nov 20, 2023 |
| PARIKH ASIT Director | Purchase at price 7.76 - 8.04 per share. | Direct | 58,580 | Nov 8, 2023 |
| HENDERSON MOLLY Chairman of the Board | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 1, 2023 |
| CURRAN TERRIE Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 1, 2023 |
| NABULSI AZMI M.D. Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 1, 2023 |
| HENDERSON MOLLY Chairman of the Board | Sale at price 7.80 - 8.95 per share. | Direct | 110,871 | Nov 1, 2023 |
| HENDERSON MOLLY Chief Financial Officer | Stock Award(Grant) at price 14.06 per share. | Direct | 351,500 | Jul 14, 2023 |
| HENDERSON MOLLY Chairman of the Board | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 14, 2023 |
| CURRAN TERRIE Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 14, 2023 |
| NABULSI AZMI M.D. Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 14, 2023 |
| PARIKH ASIT Director | Stock Award(Grant) at price 11.66 per share. | Direct | 174,900 | Jun 2, 2023 |
| HENDERSON MOLLY Chief Financial Officer | Sale at price 11.41 per share. | Direct | 22,368 | Jun 2, 2023 |
| FIELDS-KUNZ HEIDI Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 25, 2023 |
| KARBE FRANK L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 25, 2023 |
| TOPPER JAMES N Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 25, 2023 |
| SOCKS DAVID A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 25, 2023 |
| STENHOUSE MARK Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 25, 2023 |
| COLA MICHAEL F Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 25, 2023 |
| PARIKH ASIT Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 25, 2023 |
| HENDERSON MOLLY Chief Financial Officer | Sale at price 12.87 per share. | Direct | 27,165 | May 22, 2023 |
Related Tickers
RYTM Rhythm Pharmaceuticals, Inc.
59.23
-2.07%
CDTX Cidara Therapeutics, Inc.
21.98
+6.26%
URGN UroGen Pharma Ltd.
10.05
+4.04%
DAWN Day One Biopharmaceuticals, Inc.
7.33
+2.66%
MIRM Mirum Pharmaceuticals, Inc.
39.43
+2.71%
NUVB Nuvation Bio Inc.
2.0600
+4.04%
RZLT Rezolute, Inc.
3.1100
-0.96%
OLMA Olema Pharmaceuticals, Inc.
4.9600
+4.42%
ETNB 89bio, Inc.
6.55
+4.47%
STOK Stoke Therapeutics, Inc.
9.22
+7.08%